Back to top

Bear of the Day

Gentiva Health Services' (GTIV) third-quarter 2011 earnings lagged the Zacks Consensus Estimate, on the back of high interest payments as well as increasing operating expenses, thereby leading to a net loss and a negative operating cash flow. Reimbursement rate cuts and divestitures have led to reduced earnings guidance for 2011.

Ratings downgrade and legal trouble were the other downsides. Overall, the future outlook for Gentiva does not look very promising.

Our six-month target price of $5.00 equates to 3.0x our earnings estimate for 2011. This price target implies an expected total negative return of 7.9% over that period. This is consistent with our Underperform recommendation on the shares.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
CENTURY ALU… CENX 22.53 +4.50%
ERBA DIAGNO… ERB 2.91 +4.30%
PLANAR SYST… PLNR 4.31 +3.86%
MALLINCKROD… MNK 72.17 +3.83%
GTT COMMUNI… GTT 12.06 +3.52%